ANRO — Alto Neuroscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Alto Neuroscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	25.7	48.3	82.5	168
Net Total Accounts Receivable
Net Total Receivables	1.74	0.546	0.112	0.03
Prepaid Expenses
Total Other Current Assets
Total Current Assets	27.7	49.2	85.4	169
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.06	1.58	1.23	7.7
Other Long Term Assets
Total Assets	28.8	50.9	86.6	178
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.81	5.56	5.61	10
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.11	17	16.8	26.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	25.7	33.8	69.8	151
Total Liabilities & Shareholders' Equity	28.8	50.9	86.6	178
Total Common Shares Outstanding
Total Preferred Shares Outstanding